Old dogs new trick classic cancer therapies activate cGAS

A recent study has found that classic cancer therapies can activate a molecule called cGAS, which plays a role in the immune response against cancer. This discovery suggests that these traditional treatments may have additional benefits beyond their direct anti-cancer effects.

cGAS, short for cyclic GMP-AMP synthase, is a molecule that detects the presence of DNA in the cytoplasm of cells. When it detects foreign DNA, such as that from a virus or cancer cells, it triggers an immune response to eliminate the threat. However, until now, it was unclear whether cGAS could be activated by traditional cancer therapies.

The study, conducted by researchers at the University of California, San Francisco, focused on three widely used cancer treatments: radiation therapy, chemotherapy, and targeted therapy. They found that all three treatments caused DNA damage in cancer cells, leading to the release of DNA fragments into the cytoplasm. This, in turn, activated cGAS and triggered an immune response against the cancer cells.

The researchers also found that the activation of cGAS by these therapies was dependent on the presence of a molecule called STING, which is responsible for transmitting the signal from cGAS to the immune system. When they blocked STING, the immune response was significantly reduced.

These findings suggest that the immune system plays a crucial role in the effectiveness of traditional cancer therapies. By activating cGAS and triggering an immune response, these treatments not only directly kill cancer cells but also enhance the body's natural defenses against cancer.

The researchers believe that these findings could have important implications for cancer treatment. They suggest that combining traditional cancer therapies with immunotherapies that boost the immune response could lead to more effective and long-lasting outcomes for cancer patients.

Overall, this study highlights the potential of harnessing the immune system to improve cancer treatment. By understanding how traditional therapies activate immune responses, researchers can develop new strategies to enhance the body's natural defenses against cancer and improve patient outcomes